Lomas Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$59.9M Buy
1,594,396
+370,849
+30% +$12.2M 5.75% 6
2020
Q3
$40M Buy
1,223,547
+235,479
+24% +$9.97M 6.54% 6
2020
Q2
$44.8M Sell
988,068
-514,538
-34% -$26.3M 9.51% 2
2020
Q1
$68.6M Sell
1,502,606
-40,232
-3% -$1.82M 6.84% 4
2019
Q4
$66.7M Buy
1,542,838
+131,940
+9% +$5.38M 6.57% 5
2019
Q3
$51.1M Sell
1,410,898
-18,323
-1% -$772K 5.29% 7
2019
Q2
$67.2M Buy
1,429,221
+1,004,628
+237% +$42.5M 7.22% 3
2019
Q1
$14.9M Buy
424,593
+99,437
+31% +$3.91M 1.6% 22
2018
Q4
$12.2M Buy
+325,156
New +$12.7M 1.62% 21

Other funds holding ATEX

Lomas Capital Management's ATEX Position: Q4 2020 in Review

Lomas Capital Management increased its Anterix (ATEX) stake by 30% in Q4 2020, buying an estimated $12.2M and bringing the position to 1,594,396 shares worth $59.9M. The position accounts for 5.75% of the portfolio, ranked #6.

Lomas Capital Management first reported a position in ATEX in Q4 2018 and has held it in 9 quarters since. The position peaked at $68.6M in Q1 2020. 88 funds tracked by Wall St. Rank hold ATEX as of Q4 2020.

  • Lomas Capital Management held 1,594,396 shares of Anterix worth $59.9M as of Q4 2020.
  • Lomas Capital Management bought 370,849 Anterix shares in Q4 2020, an estimated $12.2M.
  • Anterix made up 5.75% of Lomas Capital Management's portfolio in Q4 2020, its #6 holding.
  • Lomas Capital Management first reported a position in Anterix in Q4 2018 and has held it in 9 quarters since.
  • Lomas Capital Management's Anterix position peaked at $68.6M in Q1 2020.
  • 88 funds tracked by Wall St. Rank held Anterix as of Q4 2020.

Based on Lomas Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.